Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

NCT02175355 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1039

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Low dose of Micardis®
DRUG: Medium dose of Micardis®
DRUG: High dose of Micardis®
DRUG: Hydrochlorothiazide
DRUG: Placebo

Sponsor

Boehringer Ingelheim